Antimicrobial Peptides Are More Than Membrane-Disrupting Molecules

Many cationic peptides associate with anionic microbial surfaces and can permeabilize membranes through transient pores, carpet-like disruption, or less uniform defects. Other peptides cross membranes and affect cell-wall synthesis, nucleic acids, ribosomes, enzymes, or stress responses. Mechanism can change with concentration, lipid composition, salt, pH, growth phase, and peptide aggregation. A simplified membrane cartoon should therefore be treated as a model rather than a complete explanation.

Minimum inhibitory concentration, killing kinetics, biofilm assays, serum stability, cytotoxicity, and animal infection models answer different questions. Media composition can bind or inactivate a peptide, and endpoint timing can alter the ranking of candidates. Activity against a laboratory strain does not establish activity in a complex infection environment. Quality records include sequence, modifications, purity, organism and strain, inoculum, medium, endpoint, controls, and replicate structure.

A useful molecule must distinguish microbial targets from host cells, retain activity in relevant biological conditions, avoid rapid degradation or sequestration, and be manufacturable with controlled impurities. Microbes can adapt through surface remodeling, proteases, efflux, biofilms, and other mechanisms. These constraints make discovery results valuable but incomplete. This page describes a research field and does not claim that an unapproved peptide treats infection or should be used by a person.